China Human Vaccine Market Share, Size, Trends, Growth, Research and Investment Prospect 2014-2018
- Submitted by: HexaReport
- Views: 61
- Category: Other
- Date Submitted: 02/25/2016 11:54 PM
- Pages: 4
- Report this Essay
Hexa Reports
Market Research Reports and Insightful Company Profiles
China Human Vaccine Market Share, Size, Trends, Growth,
Research and Investment Prospect 2014-2018
Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018, mainly studies the
market, competition pattern and segmentations of human vaccine industry in China and analyzes the
industry chain, import & export and key enterprises of human vaccine in China. This report analyzes the
business performances of 7 key enterprises, including Beijing Tiantan Biological Products Co., Ltd,
ChongQing ZhiFei Biological Products Co., Ltd, Walvax Biotechnology Co., Ltd, Liaoning Chengda Co., Ltd
(LCD) etc.
As one of powerful vaccine manufacturing countries in world, China has 42 vaccine manufacturers with
approval license. In 2013, the total of lot release quantity of vaccines was about 755 million doses,
increasing by 0.53% over the 751 million doses in 2012. Vaccine manufacturers mainly consist of stateowned enterprises, private enterprises and foreign-funded enterprises in China.
Browse Detail Report With TOC @ http://hexareports.com/report/research-and-investmentprospect-of-human-vaccine-industry-in-china/details
Seeing from the lot release quantity of vaccine in 2013, the state-owned enterprises still take the leading
position in vaccine market, with market shares of 62%, followed by private enterprises and foreignfunded enterprises successively, with market shares of 33.77% and 4.23% respectively.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Most of market of typeⅠvaccines is still dominated by state-owned enterprises, including 6 largest
institutes of China National Biotec-Group Company Limited and Changchun Keygen Biological Products
Co., Ltd. Private enterprises take half of market shares of typeⅡvaccines, the representative enterprises
include: ChongQing ZhiFei Biological Products Co., Ltd, and Walvax Biotechnology Co., Ltd etc.
While the international...
Market Research Reports and Insightful Company Profiles
China Human Vaccine Market Share, Size, Trends, Growth,
Research and Investment Prospect 2014-2018
Research and Investment Prospect of Human Vaccine Industry in China, 2014-2018, mainly studies the
market, competition pattern and segmentations of human vaccine industry in China and analyzes the
industry chain, import & export and key enterprises of human vaccine in China. This report analyzes the
business performances of 7 key enterprises, including Beijing Tiantan Biological Products Co., Ltd,
ChongQing ZhiFei Biological Products Co., Ltd, Walvax Biotechnology Co., Ltd, Liaoning Chengda Co., Ltd
(LCD) etc.
As one of powerful vaccine manufacturing countries in world, China has 42 vaccine manufacturers with
approval license. In 2013, the total of lot release quantity of vaccines was about 755 million doses,
increasing by 0.53% over the 751 million doses in 2012. Vaccine manufacturers mainly consist of stateowned enterprises, private enterprises and foreign-funded enterprises in China.
Browse Detail Report With TOC @ http://hexareports.com/report/research-and-investmentprospect-of-human-vaccine-industry-in-china/details
Seeing from the lot release quantity of vaccine in 2013, the state-owned enterprises still take the leading
position in vaccine market, with market shares of 62%, followed by private enterprises and foreignfunded enterprises successively, with market shares of 33.77% and 4.23% respectively.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Most of market of typeⅠvaccines is still dominated by state-owned enterprises, including 6 largest
institutes of China National Biotec-Group Company Limited and Changchun Keygen Biological Products
Co., Ltd. Private enterprises take half of market shares of typeⅡvaccines, the representative enterprises
include: ChongQing ZhiFei Biological Products Co., Ltd, and Walvax Biotechnology Co., Ltd etc.
While the international...